Skip to content

Inhibitory effect of cardiac resynchronization therapy on sympathetic nerve activity in chronic heart failure patients

Inhibitory effect of cardiac resynchronization therapy on sympathetic nerve activity in chronic heart failure patients - Inhibitory effect of cardiac resynchronization therapy on sympathetic nerve activity in chronic heart failure patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000010119
Enrollment
20
Registered
2013-03-01
Start date
2013-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure

Interventions

None listed

Sponsors

Internal Medicine, Kanazawa University Hospital Disease Control and Homeostasis
Lead Sponsor
Kanazawa medical center
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Twenty consecutive patients with advanced heart failure who meet clinical criteria for a CRT implantation ( LVEF<35%, NYHA function class 3 or 4, QRS durationz>120ms and optimal medical therapy).

Exclusion criteria

Exclusion criteria: Patints with recent myocardial infarction, cardiac surgery(<3 months), unstable medical conition, and chronic atrial fibrillation are excluded.

Design outcomes

Primary

MeasureTime frame
Effect of cardiac resynchronization therapy on muscle sympathetic nerve activity, 24 and 48 week after implantation.

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026